The Jeju Agricultural Technology Center and Insung Industry are carrying out an organic resource processing technology trial project using ptecticus tenebrifers, a type of fly, to deal with rotten tangerines and food waste in Jeju.
Insung Industry's breeding facility is home to tens of thousands of ptecticus tenebrifers. During the tangerine harvest season, they often consume seven to eight tons of rotting tangerines every day.
During the off-season, they consume 1.7 tons of mandarin juice residuals every day.
To allow ptecticus tenebrifers to process 40 kilos of rotting tangerines in five days, the center intends to experiment with the distribution of tiny ptecticus tenebrifer breeding facilities to nearby farmers.
Ptecticus tenebrifers larvae and adults are both approximately 20 millimeters long on average. They have an excellent ecological capacity for swallowing and decomposing organic items such as food waste.


Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
How America courted increasingly destructive wildfires − and what that means for protecting homes today
How to create a thriving forest, not box-checking ‘tree cover’
China Factory Activity Slips in January as Weak Demand Weighs on Growth Outlook
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Fungi are among the planet’s most important organisms — yet they continue to be overlooked in conservation strategies
UK Vehicle Production Falls Sharply in 2025 Amid Cyberattack, Tariffs, and Industry Restructuring
Gold Prices Hit Record High Above $5,500 as Iran Strike Fears Fuel Safe-Haven Demand
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Indonesian Stocks Plunge as MSCI Downgrade Risk Sparks Investor Exodus
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
GesiaPlatform Launches Carbon-Neutral Lifestyle App ‘Net Zero Heroes’
Dollar Struggles as Policy Uncertainty Weighs on Markets Despite Official Support
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



